Jeffrey Kaine - Concepedia

Author

Jeffrey Kaine

Also Known As

J Kaine, J L Kaine, J. Kaine, J.L Kaine, JEFFREY L. KAINE, Jeffrey Kaine, Jeffrey L Kaine, Jeffrey L. Kaine, Kaine, Jeffrey L., M. Corbo

Publications

3.2K

Citations

H-Index

Concepts

All Affiliations

Sarasota University Washington University in St. Louis Ophthalmology Consultants Rheumatology Consultants Stanford University

About

Jeffrey Kaine is an author at Sarasota University specializing in medicine, rheumatic diseases, and rheumatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	1.3K
2	Cell Biology	2	2	256
3	Natural Sciences	1	1	77
4	Biochemistry	1	1	77
5	Cellular Physiology	1	1	77

Jeffrey Kaine

Publications

Citations

H-Index

Page 1

	Year	Citations
Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial Désirée van der Heijde, James Cheng‐Chung Wei, Maxime Dougados, The Lancet InflammationRheumatologyRheumatoid DisorderAutoimmune DiseaseSpondyloarthritis	2018	349
Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate Stanley Cohen, Grant W. Cannon, Michael Schiff, Arthritis & Rheumatism Rheumatoid DisorderRheumatologyActive RaLef 26Rheumatic Diseases	2001	297
Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab. Jeffrey Kaine, Alan Kivitz, C. Birbara, PubMed	2007	243
Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial Atul Deodhar, Désirée van der Heijde, Lianne S. Gensler, The Lancet RheumatologySpondyloarthritisRheumatic DiseasesPlacebo-controlled TrialInflammatory Rheumatic Disease	2019	208
Ocrelizumab, a humanized anti‐CD20 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I/II randomized, blinded, placebo‐controlled, dose‐ranging study Mark C. Genovese, Jeffrey Kaine, Mitchell B. Lowenstein, Arthritis & Rheumatism	2008	203
Stratification, specialization, and proliferation of primary keratinocyte cultures. Evidence of a functioning in vitro epidermal cell system. Cynthia L. Marcelo, Yong‐Gil Kim, Jeffrey Kaine, The Journal of Cell Biology Skin DevelopmentPrimary Keratinocyte CulturesDevelopmental BiologyElectron MicroscopyCell Division	1978	179
The Rapid Assessment of Disease Activity in Rheumatology (Radar) Questionnaire John H. Mason, Jennifer J. Anderson, Robert F. Meenan, Arthritis & Rheumatism	1992	139
Cerebroretinal Vasculopathy M. Gilbert Grand, Jeffrey Kaine, Keith H. Fulling, Ophthalmology	1988	129
Ro (SS‐A) antibody and antigen in a patient with congenital complete heart block John B. Harley, Jeffrey Kaine, Owen F. Fox, Arthritis & Rheumatism	1985	117
Efficacy of tacrolimus in rheumatoid arthritis patients who have been treated unsuccessfully with methotrexate: A six‐month, double‐blind, randomized, dose‐ranging study Daniel E. Fürst, Kenneth G. Saag, Max Fleischmann, Arthritis & Rheumatism	2002	113

Page 1